Access India Ventures

Ownership-Driven Early-Stage Investing in Indian HealthTech and Frontier & Enabling Technologies

AIV invests in scalable, evidence-led companies through disciplined ownership, selective capital allocation, and practical exit pathways.

Leverage India's growth through 2035 by investing in Health Tech & Frontier and Enabling technologies to address critical needs in a $430 billion market.

Mission

HealthTech

Structural healthcare inefficiencies, institutional buyers, and repeatable exit pathways.

Frontier & Enabling Technologies

Selective upside beyond healthcare through software-led, scalable platforms under the same disciplined investment framework.

Investment Framework

Economic buyers, early validation, repeatable revenue, and concentrated conviction.

PROCESS

Our Approach

Strategy

• Evidence-based company selection
• Clear economic buyers
• Early commercial validation
• Repeatable revenue models
• Practical exit pathways

Our Team

• Global healthcare operating depth
• India venture execution expertise
• Local sourcing and diligence capabilities
• Sector-led investment leadership
• Disciplined portfolio construction

10 - 12 investments

• Broad sourcing across India
• Highly selective entry discipline
• Evidence-gated follow-on capital
• Concentrated conviction investing
• 10 – 12 core investments

Investment Stage

• HealthTech as core return engine
• Frontier & Enabling Technologies optionality
• Seed to Series A focus
• $250,000–$500,000 initial checks
• Upto $500,000 follow on checks
• Ownership-focused capital deployment

Core Investment Thesis

Built Around Structural Inefficiencies and Disciplined Investing

India’s valuation reset and large-scale inefficiencies create stronger opportunities for disciplined early-stage ownership.

AIV focuses on scalable businesses with validated demand, repeatable revenue models, and clear economic buyers across sectors where long-term structural demand continues to compound.

India’s valuation reset and large-scale inefficiencies create stronger opportunities for disciplined early-stage ownership.

AIV focuses on scalable businesses with validated demand, repeatable revenue models, and clear economic buyers across sectors where long-term structural demand continues to compound.

Ownership-Driven Investing

Evidence-Gated Capital Allocation

Concentrated Conviction

Practical Exit Orientation

Large underserved markets

Institutional demand expansion

Improving digital infrastructure

Expanding healthcare access

Stronger valuation discipline

Increasing acquisition pathways

Why India

India’s Next Venture Cycle Requires Discipline

India continues to present large-scale inefficiencies across healthcare, infrastructure, software enablement, and institutional workflows.

As valuation expectations normalise, early-stage ownership opportunities become increasingly attractive for disciplined investors focused on long-term value creation rather than momentum-driven deployment.

India continues to present large-scale inefficiencies across healthcare, infrastructure, software enablement, and institutional workflows.

Team

AIV Members

Throughout our journey, we have successfully closed deals, navigated exits, and cultivated enduring relationships with our partners, clients, and stakeholders.

Sid Varma

Investor at 77 Capital India, General Partner at Unilease family office. Previous experience at Commercial Bank of Dubai.

Sid Varma

Investor at 77 Capital India, General Partner at Unilease family office. Previous experience at Commercial Bank of Dubai.

Harry Paul

Former International senior roles at Roche and Boston Scientific, and CEO of Tharos. 3 years in India as General Manager for Boston Scientific.

Harry Paul

Former International senior roles at Roche and Boston Scientific, and CEO of Tharos. 3 years in India as General Manager for Boston Scientific.

Ram V

Bangalore–based Ram leads AIV’s tech-hub strategy, driving deal flow through Indian Institute of Science, IIT MedTech, and NSRCEL, backed by 25+ years in medtech, investing, and mentorship.

Ram V

Bangalore–based Ram leads AIV’s tech-hub strategy, driving deal flow through Indian Institute of Science, IIT MedTech, and NSRCEL, backed by 25+ years in medtech, investing, and mentorship.

HealthTech Focus

HealthTech as the Core Return Engine

AIV views HealthTech as one of India’s strongest long-term venture opportunities due to persistent healthcare inefficiencies, institutional buyers, recurring demand, and increasingly practical exit pathways.

The fund prioritises scalable platforms operating across healthcare delivery, operational infrastructure, diagnostics, workflow enablement, and technology-led care models.

Frontier & Enabling Technologies

Selective Exposure to Frontier & Enabling Technologies

Alongside HealthTech, AIV selectively evaluates scalable software-led and enabling technology platforms capable of generating asymmetric upside within the same disciplined investment framework.

These investments remain selectively allocated and evidence-driven rather than broad thematic exposure.

INVESTMENTS

Our Investments

Throughout our journey, we have successfully closed deals, navigated exits, and cultivated enduring relationships with our partners, clients, and stakeholders.

Track Record